s6y
Company name or ticker
Search
Biodexa Pharmaceuticals Plc
3
Parker Stephen Barry: Initial statement of beneficial ownership of securities
Filed
Friday, March 20, 2026
Period
Mar 18, 2026
Accession number
0001214659-26-003623
Documents
PRIMARY DOCUMENT
3
POA DOCUMENT
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header